These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 23182923)
21. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
22. Linear-dendritic copolymer composed of polyethylene glycol and all-trans-retinoic acid as drug delivery platform for paclitaxel against breast cancer. Li J; Jiang X; Guo Y; An S; Kuang Y; Ma H; He X; Jiang C Bioconjug Chem; 2015 Mar; 26(3):418-26. PubMed ID: 25675244 [TBL] [Abstract][Full Text] [Related]
23. Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Li S Mol Pharm; 2013 Aug; 10(8):2880-90. PubMed ID: 23768151 [TBL] [Abstract][Full Text] [Related]
24. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
25. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation. Zhang L; He Y; Ma G; Song C; Sun H Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107 [TBL] [Abstract][Full Text] [Related]
26. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
27. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
28. A PEG-Fmoc conjugate as a nanocarrier for paclitaxel. Zhang P; Huang Y; Liu H; Marquez RT; Lu J; Zhao W; Zhang X; Gao X; Li J; Venkataramanan R; Xu L; Li S Biomaterials; 2014 Aug; 35(25):7146-56. PubMed ID: 24856103 [TBL] [Abstract][Full Text] [Related]
29. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer. Peng J; Chen J; Xie F; Bao W; Xu H; Wang H; Xu Y; Du Z Biomaterials; 2019 Nov; 222():119420. PubMed ID: 31445322 [TBL] [Abstract][Full Text] [Related]
30. Improved Micellar Formulation for Enhanced Delivery for Paclitaxel. Xu J; Zhang X; Chen Y; Huang Y; Wang P; Wei Y; Ma X; Li S Mol Pharm; 2017 Jan; 14(1):31-41. PubMed ID: 28043124 [TBL] [Abstract][Full Text] [Related]
31. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases. Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349 [TBL] [Abstract][Full Text] [Related]
32. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Qu G; Yao Z; Zhang C; Wu X; Ping Q Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416 [TBL] [Abstract][Full Text] [Related]
33. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
34. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity. Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114 [TBL] [Abstract][Full Text] [Related]
36. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis. Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337 [TBL] [Abstract][Full Text] [Related]
37. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy. Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241 [TBL] [Abstract][Full Text] [Related]
38. Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo. Zhu Y; Wang X; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2017 Mar; 250():9-19. PubMed ID: 28163212 [TBL] [Abstract][Full Text] [Related]
39. Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy. Dong C; Zhou Q; Xiang J; Liu F; Zhou Z; Shen Y J Control Release; 2020 May; 321():529-539. PubMed ID: 32109513 [TBL] [Abstract][Full Text] [Related]
40. Dual pH-sensitive micelles with charge-switch for controlling cellular uptake and drug release to treat metastatic breast cancer. Tang S; Meng Q; Sun H; Su J; Yin Q; Zhang Z; Yu H; Chen L; Gu W; Li Y Biomaterials; 2017 Jan; 114():44-53. PubMed ID: 27842234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]